| Tag | Content |
|---|
EnhancerAtlas ID | HS105-59562 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chr4:6784570-6786440 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ESRRB | MA0141.3 | chr4:6786200-6786211 | TCAAGGTCAAA | + | 6.14 | | ZNF263 | MA0528.1 | chr4:6786152-6786173 | GGGTGAGGGCGGGGGGGGAGG | + | 6.25 | | ZNF263 | MA0528.1 | chr4:6786156-6786177 | GAGGGCGGGGGGGGAGGAGGA | + | 7.12 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09487 | chr4:6783542-6786295 | CD14 | | SE_54218 | chr4:6783498-6786110 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | ACTGCGGGCA GGCGGCGGGG AGGGAGGGCG CGGAGCAGCC CCTCGGCCGG GTGGGCGCGG 60
GCCGGGGAGG CCGGACGCTC GCCGCCGTGG GGCTCCGGGG CCAGCCCGAG GGAGGCCGGG 120
CCGCAGCCGA AGGCTTCGGG GTCAGCCCAA GGGAGACAGG GCCGCCGCCG TGGGCTCTGG 180
GGCCAGCCTA AGGGAGGCCG AGCCGCCGCC GAGGGCTCCG GGGCCAGCCT GAGGGAGACC 240
GGGCCGCCGC CGGGGGCTCC GGGGCCAGCC TGAGGGAGGC CGGGCCGCCG CTGATGGCTC 300
CGGGGCCAGC CTAAGGGAGA CCGGGCCGCT GTTGATGGCT CCGGGGCCAG CCGAGGGAGG 360
CCTGACCGGC CCCGATCCTG GTGGTGCCCG GGCGTGCGGG TGAGCTGTGG GCCCTGGGAC 420
CCCCGCCCCG ACCCCAGGAC GCCGGGACAC CAGCTTGCGG CTCTTGCGCC CGGGTGGGCT 480
GTGGACGATG AGTCCGCACA ATGGGTTGCC GTTGGCTGCC TCCTGCCTGG GGCAGGTGTC 540
GCCGCGCCGG GGCGGCTCTT CTAGGGGAGA CGAGGCGGGG GTGCTTAGAC TTGATAGGAC 600
GTAGAGCCCC GAAAGTGGGC GCGGGAGGAA GGCTTCGGCC GGTGGGAGGC GCCCGGCGTC 660
CCCGGCAGCG GGGTCAGGCC GGCAGCCTGG GCCGCTCGCT CGCGTTCCCT CCGTTCCCCT 720
CCCCTCCAGC ATTGTCCTTT TGGGGCCCCG GGAAGGGAAA ACCGCCGGGC GGGGGAGGAG 780
GGCCGCAGGC GGGCGGGGCC GGGAGGCCGG CTGAGCGACT GGCGCGCCGG CCTATGGCGC 840
GGGGCGCGGC GCGGGGGGCG GGCCTGGCGG GCGGGGCCGG TGCGGCGCAA GGTTTGGCGA 900
AGGTTACAGC TGGAGCTAGG AGTGACAGGC CCACAGTCAT CCGTGCGCTG CGCGGCAAAC 960
CCTGTCGCGA GGGCGCCCCG AGTTGCTGCG GGGCCTGATC CGGCTCCTTT CCAACAATAC 1020
GCGTCTGCAG CCGGCATTTC TAGAGCTCTC TGCTTCTTCC CGCTGGAGAA ACCAGTGTGT 1080
GTCGTGTTGG AATGCTTCGT CTTGCCCTAG AATTCAGCTT GCGTCTTGTG GTGCGCAGGT 1140
GACAGGACCT GCCGAACTCT TGGTACAGAC CCCTAAATCA TGGCAGAACT GTCTTGATTT 1200
CTTTTTTGCC ACCTTTCCGT TTTTGTCCTC TATAGGCAAG CTATAAAGAT TTAACCCAGT 1260
TAAAAACAGG AGGGAGATTC AGCGGAGAGG AGGCATGCGA GATTCTTTGG AAAAAATTAT 1320
ATAAATGTAG TTCTTGCTAA TAATTACCTG GGTTGGATAC TTTGACTTAC TGTTCAAGTT 1380
CCTAAGAAGG GATTTTACAT TTCTGGGTCT TGTTTTAAAA ACTGTTAGAA AGCTCGTGAG 1440
GGGGTAGGGA CAAGCAGTTT TGGTAATAGG CGATGCTGTG GATAAAACTG TGCGGTAAAA 1500
TGCCCAAGCT AGATTCTTCC TATGCAAAAT AAGACCCGTT CCAGAACACT TTGACCATTT 1560
CGTGGACTTA GAATTTAAAG GCGGGTGAGG GCGGGGGGGG AGGAGGAGCG GATTCTATCA 1620
CTCTGCATCC TCAAGGTCAA ATATTCTTCC ATCAGTTATT TTGGATTGAA CCATTCTTAA 1680
ATAGGTCTCA GGATCTCTAT GTCGCTTCCT TATGACAGAA CCTATTTCCG AGAGTGTGCC 1740
TTTGCATATC TATAGAAGCT CCTTTCACTT AATATATCTT ATAACTCAGA TTCAATTGCT 1800
GTACTTGCTA AATAATGCAT TTTTAATCAT TCAAAAAGTG GTTTACAGCT TCCTTGGGTA 1860
TAATGGTTTT 1870
|
